Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
393,180
-
Shares change
-
-7,500
-
Total reported value, excl. options
-
$60,120
-
Value change
-
-$1,000
-
Number of sells
-
-1
-
Price
-
$0.152
Significant Holders of ELITE PHARMACEUTICALS INC /NV/ - COM (ELTP) as of Q4 2016
4 filings reported holding ELTP - ELITE PHARMACEUTICALS INC /NV/ - COM as of Q4 2016.
ELITE PHARMACEUTICALS INC /NV/ - COM (ELTP) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 393,180 shares
.
Largest 5 shareholders include Geneva Advisors, LLC (293,180 shares), FISHMAN JAY A LTD/MI (60,000 shares), Sargent Bickham Lagudis LLC (40,000 shares), HALLMARK CAPITAL MANAGEMENT INC (0 shares), and PERSONAL CAPITAL ADVISORS CORP (0 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.